Stay updated on Elranatamab Combo in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Elranatamab Combo in Myeloma Clinical Trial page.

Latest updates to the Elranatamab Combo in Myeloma Clinical Trial page
- Check5 days agoChange DetectedRelated topic tags for Multiple myeloma and MedlinePlus Genetics were added, and the site revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check12 days agoChange DetectedAdded new recruitment sites (Meldola; Evangelismos General Hospital of Athens; Dr. Everett Chalmers Regional Hospital) and updated the total locations to 88 as of 2026-03-04, replacing the prior note of 85 locations.SummaryDifference0.4%

- Check19 days agoChange Detected- Removed the core topic 'Multiple Myeloma' and the related topic 'MedlinePlus Genetics' from the page.SummaryDifference0.1%

- Check27 days agoChange DetectedStudy details, eligibility criteria, and locations appear unchanged; only minor formatting/layout changes are visible. There are no new or removed substantive elements related to the trial's description or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check34 days agoChange DetectedThe page shows a new site revision (v3.4.2) and removal of a prior funding/operating-status notice (v3.4.1); these are minor maintenance updates that do not affect the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page now shows the study as Recruiting and adds many active recruitment locations worldwide. A government funding notice about NIH operations is also posted.SummaryDifference0.3%

Stay in the know with updates to Elranatamab Combo in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elranatamab Combo in Myeloma Clinical Trial page.